公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌

信达证券02-28

（以下内容从信达证券《公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌》研报附件原文摘录）鱼跃医疗(002223)本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。1、呼吸治疗和糖尿病护理...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2514357908?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-28 08:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514357908","market":"sh","top_or_hot":-1,"title":"公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌","media":"信达证券","content":"<div>\n<p>（以下内容从信达证券《公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌》研报附件原文摘录）鱼跃医疗(002223)本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。1、呼吸治疗和糖尿病护理...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-28 08:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b><strong>信达证券</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>（以下内容从信达证券《公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌》研报附件原文摘录）鱼跃医疗(002223)本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。1、呼吸治疗和糖尿病护理...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688212","symbol_name":"澳华内镜","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","article_id":"2514357908","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514357908","pubTimestamp":1740701178,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"鱼跃医疗本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","600055":"万东医疗","600529":"山东药玻","600587":"新华医疗","600645":"中源协和","600807":"济高发展","603205":"健尔康","603222":"济民健康","603301":"振德医疗","603309":"维力医疗","603387":"基蛋生物","603658":"安图生物","603880":"南卫股份","603976":"正川股份","603987":"康德莱","605369":"拱东医疗","688013":"天臣医疗","688029":"南微医学","688050":"爱博医疗","688067":"爱威科技","688068":"热景生物","688075":"安旭生物","688085":"三友医疗","688108":"赛诺医疗","688114":"华大智造","688139":"海尔生物","688151":"华强科技","688161":"威高骨科","688193":"仁度生物","688198":"佰仁医疗","688212":"澳华内镜","688217":"睿昂基因","688236":"春立医疗","688253":"英诺特","688271":"联影医疗","688273":"麦澜德","688277":"天智航","688289":"圣湘生物","688298":"东方生物","688301":"奕瑞科技","688314":"康拓医疗","688317":"之江生物","688338":"赛科希德","688351":"微电生理","688358":"祥生医疗","688366":"昊海生科","688389":"普门科技","688393":"安必平","688399":"硕世生物","688410":"山外山","688426":"康为世纪","688468":"科美诊断","688575":"亚辉龙","688576":"西山科技","688580":"伟思医疗","688581":"安杰思","688606":"奥泰生物","688607":"康众医疗","688613":"奥精医疗","688617":"惠泰医疗","688626":"翔宇医疗","688656":"浩欧博","688677":"海泰新光","688767":"博拓生物","BK0070":"员工持股","BK0251":"专用设备","BK0146":"智慧医疗","BK0114":"健康中国"},"translate_title":"Company in-depth report: \"Product + marketing\" two-wheel drive, shaping a leading brand of household medical devices","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"600055":0.9,"600529":0.9,"600587":0.9,"600645":0.9,"600807":0.9,"603205":0.9,"603222":0.9,"603301":0.9,"603309":0.9,"603387":0.9,"603658":0.9,"603880":0.9,"603976":0.9,"603987":0.9,"605369":0.9,"688013":0.9,"688029":0.9,"688050":0.9,"688067":0.9,"688068":0.9,"688075":0.9,"688085":0.9,"688108":0.9,"688114":0.9,"688139":0.9,"688151":0.9,"688161":0.9,"688193":0.9,"688198":0.9,"688212":0.9,"688217":0.9,"688236":0.9,"688253":0.9,"688271":0.9,"688273":0.9,"688277":0.9,"688289":0.9,"688298":0.9,"688301":0.9,"688314":0.9,"688317":0.9,"688338":0.9,"688351":0.9,"688358":0.9,"688366":0.9,"688389":0.9,"688393":0.9,"688399":0.9,"688410":0.9,"688426":0.9,"688468":0.9,"688575":0.9,"688576":0.9,"688580":0.9,"688581":0.9,"688606":0.9,"688607":0.9,"688613":0.9,"688617":0.9,"688626":0.9,"688656":0.9,"688677":0.9,"688767":0.9},"content_text":"（以下内容从信达证券《公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌》研报附件原文摘录）鱼跃医疗(002223)本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。1、呼吸治疗和糖尿病护理板块双轮驱动，核心业务增长强劲。①呼吸治疗业务：公司在呼吸治疗领域积淀深厚，产品矩阵丰富，能提供全套呼吸治疗相关解决方案，拳头产品如呼吸机、制氧机、高流量湿化治疗仪等，在业界享有较好的口碑，业务收入从2005年的2924万元增长到2023年的33.71亿元，年复合增长率达30.18%，我们认为随着疫情影响消退，公司呼吸治疗解决方案业务有望重回稳态增长。②糖尿病护理业务：2021年公司完成了对浙江凯立特的股权收购，布局连续血糖检测（CGM）市场，营收增长至4.57亿元（yoy+70.5%），随着公司在血糖检测领域的产品管线逐步完善，糖尿病护理方案的业务收入有望保持稳定增长态势。2、孵化潜力赛道，多元化布局，有望打造新增长点。①2019年我国每万人AED配置率不到0.2台，与发达国家相比差距较大，目前我国公共场所的AED配置率亟待提升。公司收购德国普美康，增强在急救赛道的竞争力，并抓住市场机遇，迅速参与国内商务中心、中小学校、大型企业园区、地铁等公共场所的急救设备铺设，急救业务有望保持快速发展。②2019年公司参股江苏视准，2020年公司收购六六视觉95.95%的股份，布局高景气眼科赛道，为公司未来业务发展提供新的增长动力。3、加大品牌建设，完善“OTC+医院+电商+海外”全渠道销售网络，夯实家用医疗器械龙头地位。近年来，公司加大营销投入，持续完善“OTC+医院+电商+海外”全渠道销售网络，其中电商业务依托互联网蓬勃发展的春风，销售额逐年走高，从2015年的6.67亿元增长到2024年的34.20亿元，年复合增长率为19.92%，2022年线上业务占比已超60%。在品牌力方面，依托鱼跃产品力的不断提升及有效的品牌传播，以及旗下产品在海内外医疗一线的突出表现，公司品牌价值和品牌优势显著提升，客户粘性进一步增强，龙头地位得以夯实。盈利预测与投资评级：我们预计公司2024-2026年营业收入分别为78.05、89.75、104.00亿元，同比增速分别为-2.1%、15.0%、15.9%，归母净利润分别为19.04、23.04、27.60亿元，同比增速分别为-20.5%、21.0%、19.8%，对应当前股价PE分别为20、16、14倍，首次覆盖，给予“买入”投资评级。风险提示：线上平台竞争加剧风险；海外市场拓展不及预期风险；并购整合不及预期及商誉减值的风险。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514357908"}